2m 2m 2m 2m 2m 2m 2m
Oramed (ORMP)
NASDAQ
$3.46-$0.14 (-3.89%)
Price as of Jun 03, 2026 7:38 PM EDT- $162.5MMarket Cap
- 70.87%1-Year Change
- BiotechnologyIndustry
Oramed (ORMP)
$3.46-$0.14 (-3.89%)
ORMP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.60 | ||
Change | -$0.29 (-7.46%) | ||
Open | $3.85 | ||
High | $3.96 | ||
Low | $3.58 | ||
Previous Close | $3.89 | ||
Volume | 395,150 | ||
30-Day Average Volume | 214,160 | ||
1-Week Change | -10.89% | ||
1-Month Change | -9.55% | ||
1-Year Change | 70.87% | ||
3-Year Change | -3.94% | ||
5-Year Change | -68.11% | ||
Fundamentals | |||
Shares Outstanding | 40.9M | ||
Total Assets | $230.9M | ||
Market Cap | $162.5M | ||
Enterprise Value | $118.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | $15.8M | ||
Free Cash Flow | -$468,000.00 | ||
EBIT | $15.6M | ||
EBITDA | $15.6M | ||
Net Working Capital | $114.2M | ||
EPS | $0.37 | ||
Enterprise Value/EBITDA | 8 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | 11 | ||
PEG | -0 | ||
Price/Free Cash Flow | -347 | ||
Price/Operating Cash Flow | -349 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | 62.50% | ||
Trailing Annual Dividend Yield | 6.94% | ||
Ex-Dividend Date | 01/16/2026 | ||
Last Split Factor | 1 : 12 | ||
Last Split Date | 01/23/2013 | ||
Earnings & Revenue
Annual Dividend Yield